April 8, 2019
Histogenics (HSGX) reverse mergers with Ocugen, Inc.
February 26, 2019
Sage Therapeutics (SAGE) prices 3.33 M share offering at $150.00
January 15, 2019
Alnylam Pharmaceuticals (ALNY) priced 5 M share offering at $77.50
August 8, 2018
REGENXBIO (RGNX) proposes a $175 M offering
June 14, 2018
Verastem Oncology (VSTM) a registered stock sale
April 4, 2018
Cellectis (CLLS) prices follow-on $175 M ADS offering
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at firstname.lastname@example.org.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors